THE GREATEST MEDICINE OF ALL… IS TEACHING PEOPLE HOW NOT TO NEED IT
IF YOU DON’T MAKE TIME FOR YOUR WELLNESS - YOU WILL BE FORCED TO MAKE TIME FOR YOUR ILLNESS!
If you decide to get a Covid Vaccine shot, your best choice looks like it will be Moderna’s vaccine. As this new study below shows, Moderna’s vaccine is considerably safer.
Pfizer Recipients Face 37% Higher Risk of Death Than Moderna Recipients
Study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.
The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:
All-Cause Mortality
Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.
· Pfizer Risk: 847.2 deaths per 100,000 people· Moderna Risk: 617.9 deaths per 100,000 people
➔ +229.2 deaths per 100,000 (Pfizer excess)
· Risk Ratio (RR):
➔ 1.37 (i.e., 37% higher mortality risk with Pfizer)
· Odds Ratio (Adjusted):
➔ 1.384 (95% CI: 1.331–1.439)
Cardiovascular Mortality
Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.
· Pfizer Risk: 248.7 deaths per 100,000 people· Moderna Risk: 162.4 deaths per 100,000 people
· Risk Difference:
➔ +86.3 deaths per 100,000 (Pfizer excess)
· Risk Ratio (RR):
➔ 1.53 (i.e., 53% higher cardiovascular mortality risk)
· Odds Ratio (Adjusted):
➔ 1.540 (95% CI: 1.431–1.657)
COVID-19 Mortality
Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.
· Pfizer Risk: 55.5 deaths per 100,000 people
· Moderna Risk: 29.5 deaths per 100,000 people
· Risk Difference:
➔ +26.0 deaths per 100,000 (Pfizer excess)
· Risk Ratio (RR):
➔ 1.88 (i.e., 88% higher COVID-19 mortality risk)
· Odds Ratio (Adjusted):
➔ 1.882 (95% CI: 1.596–2.220)
Non-COVID-19 Mortality
Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.
· Pfizer Risk: 791.6 deaths per 100,000 people
· Moderna Risk: 588.4 deaths per 100,000 people
· Risk Difference:
➔ +203.3 deaths per 100,000 (Pfizer excess)
· Risk Ratio (RR):
➔ 1.35 (i.e., 35% higher non-COVID mortality risk)
· Odds Ratio (Adjusted):
➔ 1.356 (95% CI: 1.303–1.412)
Biological Explanations
The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:
The paper hypothesizes differences between Pfizer and Moderna may be due to:
· Different lipid nanoparticle compositions· Differences in manufacturing, biodistribution, or storage conditions
Final Conclusion
Florida adults who received Pfizer's BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.
Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.
As the authors conclude:
These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.
Nicolas Hulscher, MPHEpidemiologist and Foundation Administrator, McCullough Foundation
Berberine Outshines Metformin for Diabetes
Written By: GreenMedInfo Research Group
Berberine, an alkaloid prized in traditional Chinese medicine, offers powerful antidiabetic effects that, in some cases, work better than metformin for Type 2 diabetes
Berberine is an alkaloid found in plants like barberry, goldenseal and goldthread. It's been treasured as an integral part of traditional Chinese medicine since ancient times, with its earliest known medical use dating back to A.D. 200. If you have diabetes, or prediabetes, this is one compound to be aware of, as it has powerful antidiabetic properties.
In addition to anti-inflammatory and lipid-lowering effects, berberine impacts carbohydrate metabolism, increases insulin sensitivity and decreases insulin resistance. Berberine is, in many ways, a natural alternative to the diabetes drug metformin.
With rates of Type 2 diabetes increasing worldwide -- by 2050, it's estimated 1.31 billion people will have diabetes -- antidiabetic compounds like berberine should be on your radar.
Berberine Works as Well as -- or Better Than -- Metformin for Diabetes
In 2020, there were more than 92 million prescriptions written for metformin, which can lead to lactic acidosis -- a dangerous buildup of lactic acid in the bloodstream that's fatal in about 50% of cases. There is another option, however -- Berberine.
In a study of 36 adults with newly diagnosed Type 2 diabetes, subjects received either berberine or metformin for three months. "The hypoglycemic effect of berberine was similar to that of metformin," the researchers found, with significant decreases in A1c -- a measure of average blood sugar levels over the last three months -- fasting blood glucose, postprandial blood glucose and plasma triglycerides in the berberine group.
In the second part of the study, 48 adults with poorly controlled Type 2 diabetes received berberine for three months. The compound was beneficial in this group as well, lowering fasting blood glucose and postprandial blood glucose. Further, A1c decreased from 8.1% to 7.3% while fasting plasma insulin was reduced by 28.1%. Total cholesterol and low-density lipoprotein cholesterol also went down.
Berberine's antidiabetic activity was as good as, or better than, metformin. The two performed equally for glucose metabolism, but berberine far outshined metformin when it came to lipid metabolism. The study found:
"Compared with metformin, berberine exhibited an identical effect in the regulation of glucose metabolism, such as HbA1c, FBG [fasting blood glucose], PBG [postprandial blood glucose], fasting insulin and postprandial insulin. In the regulation of lipid metabolism, berberine activity is better than metformin. By week 13, triglycerides and total cholesterol in the berberine group had decreased and were significantly lower than in the metformin group."
Berberine also significantly enhanced insulin sensitivity in the diabetic patients, which the researcher suggested may be due to alterations in fat distribution. While the subjects had no changes in weight, the berberine groups experienced significant decreases in waist size and waist-to-hip ratio.
A systematic review and meta-analysis involving 37 studies and 3,048 patients also found berberine significantly reduced fasting blood glucose, A1c and blood sugar two hours after eating. The analysis also looked for adverse effects and found berberine to be safe, noting, "Treatment with berberine may be safe since it does not increase the incidence of total adverse events and the risk of hypoglycemia."
Berberine May Benefit 303 Diseases
Berberine offers health benefits beyond diabetes, as well. In fact, because it interacts with numerous targets in your body, it may offer benefits for multiple diseases at once.
"Berberine works at a cellular level and changes how cells work by turning things off and on," functional medicine specialist Dr. Elizabeth Bradley told Cleveland Clinic. "Its basic interactions involve so many different processes in the body." Other top reasons to consider berberine include:
1. Obesity -- Berberine has antiobesity effects and has even been dubbed "nature's Ozempic," referring to the popular diabetes-turned-weight-loss drug. A systematic review and meta-analysis of 12 studies found berberine significantly decreased body weight, body mass index, waist circumference and C-reactive protein, a measure of inflammation.
2. Cancer -- Berberine is effective against multiple types of cancer and is known to induce apoptosis and autophagy while inhibiting metastasis and invasion. Research suggests berberine may target pancreatic, gastric and ovarian cancers, along with leukemia, multiple myeloma and glioblastoma, among others.
3. Nonalcoholic fatty liver disease (NAFLD) -- Due to its ability to positively influence multiple metabolic pathways and modulate gut microbiota, berberine is believed to be protective against NAFLD.
4. Heart disease -- Berberine's lipid-lowering, anti-inflammatory effects make it useful for targeting cardiovascular diseases (CVDs). A systematic review and meta-analysis found berberine reduced National Institute of Health Stroke Scale score as well as C-reactive protein and intima-media thickness, a measure of atherosclerotic vascular disease, such that "berberine may be a promising alternative for CVDs with no serious adverse reactions.”
Garlic Beats Drug in Detoxifying Lead Safely From Body
Garlic is used the world over as a culinary spice, but recent research indicates that among its 100+ medicinal properties it is far safer and more effective than a commonly used chelation drug in pulling lead out of the human body.
A remarkable study published in the journal Basic & Clinical Pharmacology & Toxicology revealed something very special about garlic: it is a natural detoxifier of lead and is not only as effective as a common chelation drug known as d-penicillamine at pulling this metal out of the body but is also much safer.
The study was titled, "Comparison of therapeutic effects of garlic and d-penicillamine in patients with chronic occupational lead poisoning," and sought to confirm previous research in animals that showed garlic (Allium sativum) is effective in reducing blood and tissue lead concentrations.
The study took the measurements of the blood lead concentrations of 117 workers at a car battery plant who were randomly assigned to two groups of garlic (1.2 milligrams of allicin from approximately 1,000 mg of garlic extract, three times daily) and d-penicillamine (250 mg, three times daily) and treated for 4 weeks. Clinical signs and symptoms of lead poisoning were also investigated and compared with the initial findings.
The study found:
"Clinical improvement was significant in a number of clinical manifestations. The frequency of side effects was significantly (p=0.023) higher in d-penicillamine than in the garlic group. Thus, garlic seems safer clinically and as effective as d-penicillamine. Therefore, garlic can be recommended for the treatment of mild-to-moderate lead poisoning."
Clearly, despite the near equal reduction in measurable blood lead concentrations in both groups, improvements in various measured clinical manifestations were only found in the garlic group. Also, side effects were higher in the d-penicillamine group. These results clearly indicate the superiority of garlic over the drug and underscore how drug-based interventions often end up 'normalizing' target values, e.g. blood lead concentrations, without resulting in improvement in the quality of life or even the objective clinical signs and subjective symptoms of the treated patient; to the contrary, often the patient feels and is much worse off following drug treatment.
Lead exposure is ubiquitous in our modern age, and has been estimated to account for approximately 0.2% of all deaths and 0.6% of disability adjusted life years globally. Exposure to this heavy metal results in harm to the cardiovascular, skeletal, gastrointestinal, kidney, reproductive and nervous systems of the human body. It has been identified to be particularly harmful to infants and children, whose developing nervous systems are far more susceptible to lead toxicity than those of adults. In fact, a 2008 PLoS study found decreased brain volume in adults who had been exposed to lead as children.
The standard of care involving drugs such as d-penicillamine is dismal, considering that the chemical has been linked to the following side effects:
· Anemia, Aplastic· Breast Enlargement
· Anorexia
· Bone Marrow Suppression
· Collagen Disorders
· Diarrhea
· Dysgeusia (distorted taste)
· Kidney Damage
· Liver Damage
· Muscle Damage
The chemical is so toxic that the total incidence of side effects from d-penicillamine treatment is 30-60%, with a withdrawal rate of 20-30%.
Garlic, on the other hand, is a commonly enjoyed culinary spice worldwide with a wide range of potential side benefits and a high margin of safety. In a previous article titled, How Garlic Can Save Your Life, we discussed the sizable body of research gathered on the GreenMedInfo.com database on the over 150 health conditions garlic has been researched to be potentially beneficial for.
Additionally, our open access database project, which now contains over 3000 ailments indexed, has a section on "Lead Poisoning," which includes research on 23 substances that may help ameliorate the effects of lead exposure and/or toxicity, and which can be viewed here: Natural Agents for Lead Poisoning.
Until next time, stay healthy and happy
J.D. Roma
The information on this blog is provided for educational purposes only. It is not a substitute for professional medical care, and medical advice and services are not being offered. If you have, or suspect you have, a health problem you should consult your physician (preferably a Naturopath).
No comments:
Post a Comment